118 related articles for article (PubMed ID: 1706995)
21. Bleomycin-Induced Pulmonary Changes on Restaging Computed Tomography Scans in Two Thirds of Testicular Cancer Patients Show No Correlation With Fibrosis Markers.
den Hollander MW; Westerink ND; Lubberts S; Bongaerts AH; Wolf RF; Altena R; Nuver J; Oosting SF; de Vries EG; Walenkamp AM; Meijer C; Gietema JA
Oncologist; 2016 Aug; 21(8):995-1001. PubMed ID: 27328932
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and Cisplatin.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Daugaard G
Eur Urol Focus; 2018 Jul; 4(4):591-598. PubMed ID: 28753832
[TBL] [Abstract][Full Text] [Related]
23. Vinblastine, cisplatin and bleomycin (VPB) adjuvant therapy does not induce dose-dependent damage in human chromosomes.
Gundy S; Baki M; Bodrogi I
Neoplasma; 1989; 36(4):457-64. PubMed ID: 2475796
[TBL] [Abstract][Full Text] [Related]
24. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group.
de Wit R; Stoter G; Kaye SB; Sleijfer DT; Jones WG; ten Bokkel Huinink WW; Rea LA; Collette L; Sylvester R
J Clin Oncol; 1997 May; 15(5):1837-43. PubMed ID: 9164193
[TBL] [Abstract][Full Text] [Related]
25. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of long-term toxicity after chemotherapy for testicular cancer.
Bokemeyer C; Berger CC; Kuczyk MA; Schmoll HJ
J Clin Oncol; 1996 Nov; 14(11):2923-32. PubMed ID: 8918489
[TBL] [Abstract][Full Text] [Related]
27. Analysis of human sperm karyotypes in testicular cancer patients before and after chemotherapy.
Martin RH; Ernst S; Rademaker A; Barclay L; Ko E; Summers N
Cytogenet Cell Genet; 1997; 78(2):120-3. PubMed ID: 9371403
[TBL] [Abstract][Full Text] [Related]
28. Left ventricular and cardiac autonomic function in survivors of testicular cancer.
Nuver J; Smit AJ; Sleijfer DT; van Gessel AI; van Roon AM; van der Meer J; van den Berg MP; Hoekstra HJ; Sluiter WJ; Gietema JA
Eur J Clin Invest; 2005 Feb; 35(2):99-103. PubMed ID: 15667580
[TBL] [Abstract][Full Text] [Related]
29. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
[TBL] [Abstract][Full Text] [Related]
30. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
Srougi M; Simon SD; de Góes GM
J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
[TBL] [Abstract][Full Text] [Related]
31. [Detection of functional changes in the myocardium after chemotherapy using radionuclide ventriculography in patients with testicular tumors].
Brousil J; Foltýnová V; Bĕlohlávek O; Abrahámová J
Bratisl Lek Listy; 1989 Sep; 90(9):637-9. PubMed ID: 2480175
[TBL] [Abstract][Full Text] [Related]
32. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
[TBL] [Abstract][Full Text] [Related]
33. [A case of pneumomediastinum during BEP (bleomycin, etoposide, cisplatin) chemotherapy for testicular cancer].
Noguchi G; Ota J; Ishigaki H; Onuki T; Kato Y; Moriyama M
Hinyokika Kiyo; 2013 Aug; 59(8):545-9. PubMed ID: 23995535
[TBL] [Abstract][Full Text] [Related]
34. Enhanced effects of bleomycin on pulmonary function disturbances in patients with decreased renal function due to cisplatin.
Sleijfer S; van der Mark TW; Schraffordt Koops H; Mulder NH
Eur J Cancer; 1996 Mar; 32A(3):550-2. PubMed ID: 8814706
[TBL] [Abstract][Full Text] [Related]
35. Vinblastine, cisplatin and bleomycin treatment of advanced nonseminomatous testicular tumors.
Bodrogi I; Baki M; Horti J; Liszka G; Ottó S; Hindy I; Sugár J; Eckhardt S
Neoplasma; 1990; 37(4):445-50. PubMed ID: 1700311
[TBL] [Abstract][Full Text] [Related]
36. [Randomized phase III study on nonseminomatous testicular tumor].
Rexer H
Urologe A; 2004 Nov; 43(11):1432-3. PubMed ID: 15526083
[No Abstract] [Full Text] [Related]
37. Growth differentiation factor 15 (GDF-15) plasma levels increase during bleomycin- and cisplatin-based treatment of testicular cancer patients and relate to endothelial damage.
Altena R; Fehrmann RS; Boer H; de Vries EG; Meijer C; Gietema JA
PLoS One; 2015; 10(1):e0115372. PubMed ID: 25590623
[TBL] [Abstract][Full Text] [Related]
38. Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors.
Boer H; Westerink NL; Altena R; Nuver J; Dijck-Brouwer DAJ; van Faassen M; Klont F; Kema IP; Lefrandt JD; Zwart N; Boezen HM; Smit AJ; Meijer C; Gietema JA
Eur J Cancer; 2016 Feb; 54():104-111. PubMed ID: 26751392
[TBL] [Abstract][Full Text] [Related]
39. Treatment Results of Extracranial Malignant Germ Cell Tumor with Regimens of Cisplatin, Vinblastine, Bleomycin or Carboplatin, Etoposide, and Bleomycin with Special Emphasis on the Sites of Vagina and Testis.
Hou JY; Liu HC; Yeh TC; Sheu JC; Chen KH; Chang CY; Liang DC
Pediatr Neonatol; 2015 Oct; 56(5):301-6. PubMed ID: 25769700
[TBL] [Abstract][Full Text] [Related]
40. The role of induction and maintenance chemotherapy in disseminated testicular non-seminomatous cancer.
van Groeningen CJ; Stoter G
Prog Clin Biol Res; 1984; 153():225-32. PubMed ID: 6206508
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
